A detailed history of Diversified Enterprises, LLC transactions in Amgen Inc stock. As of the latest transaction made, Diversified Enterprises, LLC holds 782 shares of AMGN stock, worth $267,217. This represents 0.01% of its overall portfolio holdings.

Number of Shares
782
Previous 813 3.81%
Holding current value
$267,217
Previous $227 Million 2.73%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025

SELL
$271.18 - $309.22 $8,406 - $9,585
-31 Reduced 3.81%
782 $221 Million
Q2 2025

Jul 16, 2025

SELL
$262.28 - $309.85 $138,746 - $163,910
-529 Reduced 39.42%
813 $227 Million
Q1 2025

May 15, 2025

BUY
$258.59 - $327.36 $86,627 - $109,665
335 Added 33.27%
1,342 $418 Million
Q4 2024

Feb 10, 2025

BUY
$258.78 - $328.31 $28,724 - $36,442
111 Added 12.39%
1,007 $263 Million
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $277,204 - $302,292
896 New
896 $289 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Diversified Enterprises, LLC Portfolio

Follow Diversified Enterprises, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Enterprises, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Enterprises, LLC with notifications on news.